Search Results - "Claudia, Lefeuvre"

Genomic characterization of metastatic breast cancers by Bertucci, François, Ng, Charlotte K. Y., Patsouris, Anne, Droin, Nathalie, Piscuoglio, Salvatore, Carbuccia, Nadine, Soria, Jean Charles, Dien, Alicia Tran, Adnani, Yahia, Kamal, Maud, Garnier, Séverine, Meurice, Guillaume, Jimenez, Marta, Dogan, Semih, Verret, Benjamin, Chaffanet, Max, Bachelot, Thomas, Campone, Mario, Lefeuvre, Claudia, Bonnefoi, Herve, Dalenc, Florence, Jacquet, Alexandra, De Filippo, Maria R., Babbar, Naveen, Birnbaum, Daniel, Filleron, Thomas, Le Tourneau, Christophe, André, Fabrice

“…Metastasis is the main cause of death for patients with breast cancer. Many studies have characterized the genomic landscape of breast cancer during its early…”
Get full text

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) by André, Fabrice, Prof, Bachelot, Thomas, MD, Commo, Frederic, MSc, Campone, Mario, Prof, Arnedos, Monica, MD, Dieras, Véronique, MD, Lacroix-Triki, Magali, MD, Lacroix, Ludovic, PharmPhD, Cohen, Pascale, PhD, Gentien, David, MSc, Adélaide, Jose, PhD, Dalenc, Florence, MD, Goncalves, Anthony, MD, Levy, Christelle, MD, Ferrero, Jean-Marc, Prof, Bonneterre, Jacques, Prof, Lefeuvre, Claudia, MD, Jimenez, Marta, MSc, Filleron, Thomas, PhD, Bonnefoi, Hervé, Prof

“…Summary Background Breast cancer is characterised by genomic alterations. We did a multicentre molecular screening study to identify abnormalities in…”
Get full text

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy by Zelek, Laurent, Debourdeau, Philippe, Bourgeois, Hugues, Wagner, Jean Philippe, Brocard, Fabien, Lefeuvre‐Plesse, Claudia, Chauffert, Bruno, Leheurteur, Marianne, Bachet, Jean‐Baptiste, Simon, Hélène, Mayeur, Didier, Scotté, Florian

“…Background Neurokinin (NK) 1 receptor antagonists (RAs), administered in combination with a 5‐hydroxytryptamine‐3 (5‐HT3) RA and dexamethasone (DEX), have…”
Get full text

Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients by Corné, Julien, Le Du, Fanny, Quillien, Véronique, Godey, Florence, Robert, Lucie, Bourien, Héloïse, Brunot, Angélique, Crouzet, Laurence, Perrin, Christophe, Lefeuvre-Plesse, Claudia, Diéras, Véronique, De la Motte Rouge, Thibault

“…With the approval of new therapies targeting the PI3K pathway, the detection of PIK3CA mutations has become a key factor in treatment management for HR+/HER2−…”
Get full text

Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress by Baudry, Anne‐Sophie, Yakimova, Sonya, Congard, Anne, Untas, Aurélie, Guiu, Séverine, Lefeuvre‐Plesse, Claudia, Loustalot, Catherine, Guillemet, Cécile, Segura‐Djezzar, Carine, Savoye, Aude‐Marie, Coussy, Florence, Frenel, Jean‐Sébastien, Vanlemmens, Laurence, Christophe, Véronique

“…Objective Emotional competence (EC) is considered a substantial resource in the adjustment of cancer patients, especially via its effect on anxiety and…”
Get full text

Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer by Corné, Julien, Quillien, Véronique, Godey, Florence, Cherel, Mathilde, Cochet, Agathe, Le Du, Fanny, Robert, Lucie, Bourien, Héloïse, Brunot, Angélique, Crouzet, Laurence, Perrin, Christophe, Lefeuvre‐Plesse, Claudia, Diéras, Véronique, De la Motte Rouge, Thibault

“…Erb‐b2 receptor tyrosine kinase 2 (ERBB2)‐activating mutations are therapeutically actionable alterations found in various cancers, including metastatic breast…”
Get full text

Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial by Jacot, William, Arnaud, Antoine, Jarlier, Marta, Lefeuvre-Plesse, Claudia, Dalivoust, Philippe, Senesse, Pierre, Azzedine, Ahmed, Tredan, Olivier, Sadot-Lebouvier, Sophie, Mas, Sébastien, Carayol, Marion, Bleuse, Jean-Pierre, Gourgou, Sophie, Janiszewski, Chloé, Launay, Silene, D'Hondt, Véronique, Lauridant, Géraldine, Grenier, Julien, Romieu, Gilles, Ninot, Gregory, Vanlemmens, Laurence

“…Supervised exercise dietary programs are recommended to relieve cancer-related fatigue and weight increase induced by adjuvant treatment of early breast cancer…”
Get full text

Jaw osteonecrosis in patients treated with denosumab 120 mg with regular dental monitoring: 4-year retrospective study by Beaudouin, Sophie, Scailteux, Lucie-Marie, Lefeuvre, Claudia, Gamby, Romain, Cairon-Lejeune, Sophie

“…Background: Medication-related osteonecrosis of the jaw (MRONJ) is an expected, but rare adverse effect of denosumab. There are few data denosumab 120 mg…”
Get full text

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer by Ray-Coquard, Isabelle, Pautier, Patricia, Pignata, Sandro, Pérol, David, González-Martín, Antonio, Berger, Regina, Fujiwara, Keiichi, Vergote, Ignace, Colombo, Nicoletta, Mäenpää, Johanna, Selle, Frédéric, Sehouli, Jalid, Lorusso, Domenica, Guerra Alía, Eva M, Reinthaller, Alexander, Nagao, Shoji, Lefeuvre-Plesse, Claudia, Canzler, Ulrich, Scambia, Giovanni, Lortholary, Alain, Marmé, Frederik, Combe, Pierre, de Gregorio, Nikolaus, Rodrigues, Manuel, Buderath, Paul, Dubot, Coraline, Burges, Alexander, You, Benoît, Pujade-Lauraine, Eric, Harter, Philipp

“…When used as maintenance therapy, the PARP inhibitor olaparib provided a significant progression-free survival benefit in women with ovarian cancer who had a…”
Get full text

A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy by Le Rhun, Emilie, Delbeuck, Xavier, Lefeuvre-Plesse, Claudia, Kramar, Andrew, Skrobala, Emilie, Pasquier, Florence, Bonneterre, Jacques

“…Cognitive impairment, especially verbal episodic memory and executive function impairments, has been considered to be a possible adverse effect of aromatase…”
Get full text

Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network by Nigon, Elsa, Lefeuvre-Plesse, Claudia, Martinez, Alejandra, Chauleur, Céline, Lortholary, Alain, Favier, Laure, Bats, Anne-Sophie, Guille, Arnaud, AdélaÏde, José, Finetti, Pascal, de Casteljac, Victoire, Provansal, Magali, Mamessier, Emilie, Bertucci, François, Ray-Coquard, Isabelle, Sabatier, Renaud

“…Uterine clear cell carcinomas (CCC) represent less than 5% of uterine cancers. Their biological characteristics and clinical management remain uncertain. A…”
Get full text

Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trial by Joly, Florence, Lefeuvre-Plesse, Claudia, Garnier-Tixidre, Claire, Helissey, Carole, Menneveau, Nathalie, Zannetti, Alain, Salas, Sebastien, Houede, Nadine, Abadie-Lacourtoisie, Sophie, Stefani, Laetitia, Nenan, Soazig, Rieger, Isabelle, Durand-Zaleski, Isabelle, Descotes, Jean-Marc, Anota, Amélie

“…Currently, oral targeted therapies are known to be effective and are frequently used to treat metastatic cancer patients, but fatigue is a frequently reported…”
Get full text

Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial by Bachelot, Thomas, Filleron, Thomas, Bieche, Ivan, Arnedos, Monica, Campone, Mario, Dalenc, Florence, Coussy, Florence, Sablin, Marie-Paule, Debled, Marc, Lefeuvre-Plesse, Claudia, Goncalves, Anthony, Reynier, Marie-Ange Mouret, Jacot, William, You, Benoit, Barthelemy, Philippe, Verret, Benjamin, Isambert, Nicolas, Tchiknavorian, Xavier, Levy, Christelle, Thery, Jean-Christophe, L’Haridon, Tifenn, Ferrero, Jean-Marc, Mege, Alice, Del Piano, Francesco, Rouleau, Etienne, Tran-Dien, Alicia, Adam, Julien, Lusque, Amelie, Jimenez, Marta, Jacquet, Alexandra, Garberis, Ingrid, Andre, Fabrice

“…The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer…”
Get full text

Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients by LESIMPLE, Thierry, NEIDHARD, Eve-Marie, BIREBENT, Brigitte, PHILIP, Irène, TOUJAS, Louis, CHOKRI, Mohamed, QUILLIEN, Véronique, VIGNARD, Virginie, LEFEUVRE, Claudia, ADAMSKI, Henri, LABARRIERE, Nathalie, CARSIN, André, MONNIER, Delphine, COLLET, Brigitte, CLAPISSON, Gilles

“…Purpose: A phase I/II trial was conducted to evaluate clinical and immunologic responses after intralymphatic and intranodal injections of mature dendritic…”
Get full text

Biodistribution of radiolabelled human dendritic cells injected by various routes by Quillien, Véronique, Moisan, Annick, Carsin, Andre, Lesimple, Thierry, Lefeuvre, Claudia, Adamski, Henri, Bertho, Nicolas, Devillers, Anne, Leberre, Claudine, Toujas, Louis

“…The purpose of this study was to investigate the biodistribution of mature dendritic cells (DCs) injected by various routes, during a cell therapy protocol. In…”
Get full text

Osteonecrosis of the jaw under palbociclib: A case series description by Yosofi, Chabnam, Cairon-Lejeune, Sophie, Lefeuvre-Plesse, Claudia, Polard, Elisabeth, Briet, Marie, Kammerer-Jacquet, Solène-Florence, Triquet, Louise, Scailteux, Lucie-Marie

“…Introduction Cases of osteonecrosis of the jaw have been reported by dental surgeons to the pharmacovigilance center in Rennes, France, occurring among…”
Get full text

Impact of EPclin on adjuvant therapeutic decision making and comparison of EPclin to the PREDICT tool by Bourien, Héloïse, Quillien, Véronique, Godey, Florence, Perrin, Christophe, Le Du, Fanny, Guillermet, Sophie, Blanchot, Jérôme, Lavoué, Vincent, Campillo-Gimenez, Boris, Brunot, Angélique, Crouzet, Laurence, De la Motte Rouge, Thibault, Diéras, Véronique, Lefeuvre-Plesse, Claudia

“…Purpose: Genomic signatures, such as EndoPredict®, may help clinicians to decide which adjuvant treatment is the most appropriate. Methods: We propose the…”
Get full text

BP54 - KNOWLEDGE AND CARE PATHWAY EVOLUTION FOR PATIENTS WITH METASTATIC BREAST CANCER BETWEEN 2015 AND 2021: RESULTS’ COMPARISON OF THE RÉALITÉS 1 AND 2 FRENCH SURVEYS by Claudia, Lefeuvre, Jean-Sebastien, Frenel, Isabelle, Moley-Massol, Laure, Guéroult-Accolas, Dominique, Debiais, Séverine, Guiu

Get full text

KNOWLEDGE AND CARE PATHWAY EVOLUTION FOR PATIENTS WITH METASTATIC BREAST CANCER BETWEEN 2015 AND 2021: RESULTS’ COMPARISON OF THE RÉALITÉS 1 AND 2 FRENCH SURVEYS by Claudia, Lefeuvre, Jean-Sebastien, Frenel, Isabelle, Moley-Massol, Laure, Guéroult-Accolas, Dominique, Debiais, Séverine, Guiu

Get full text

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study by Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., Fallowfield, Lesley, Jenkins, Valerie, Kilkerr, Justine, Langridge, Carolyn, Monson, Kathryn, Jakobsen, Erik Hugger, Nielsen, Mette Holck, Linnet, Soeren, Knoop, Ann, Pivot, Xavier, Bonnefoi, Herve, Mousseau, Mireille, Zelek, Laurent, Bourgeois, Hugues, Lefeuvre, Claudia Plesse, Bachelot, Thomas, Petit, Thierry, Brain, Etienne, Levy, Christelle, Gligorov, Joseph, Augustin, Doris, Graf, Heiko, Heinrich, Georg, Kroening, Hendrik, Kuemmel, Sherko, Müller, Volkmar, Overkamp, Friedrich, Park-Simon, Tjoung-Won, Schmidt, Marcus, Perlova-Griff, Lidia, Wolf, Christopher, Colleoni, Marco, Ballestrero, Alberto, Bernardo, Antonio, Ribecco, Angela Stefania, Gianni, Luca, Curigliano, Giuseppe, Brewczynska, Elżbieta, Jassem, Jacek, Shirinkin, Vadim, Manikhas, Alexey, Dvornichenko, Victoria, Lichinitser, Mikhail, Semiglazov, Vladimir, Mukhametshina, Guzel, Bulavina, Irina, Arranz, Enrique Espinosa, Ocon, Francisco Carabantes, Vivanco, Guillermo López, Bofill, Javier Salvador, Quintela, Ignacio Porras, Muñoz, Alfonso Sanchez, Pérez, Yolanda Fernández, Espinosa, Javier Cassinello, Alvarez, José Valero, del Prado, Rodrigo Lastra, De Merino, LuisLa Cruz, García, José Manuel Pérez, Frances, Santos Enrech, Edlund, Per, Norberg, Bengt, Wennstig, Anna-Karin, Lind, Pehr, Hauser, Nik, Tausch, Christoph, Camci, Celalettin, Arpaci, Fikret, Abali, Huseyin, Uslu, Ruchan, Tahir, Saad, Wheatley, Duncan, Chan, Stephen, Barrett-Lee, Peter, McAdam, Karen, Simcock, Richard, Burcombe, Russell, El-Maraghi, Robert, Califaretti, Nadia, Spadafora, Silvana, Sehdev, Sandeep, Sami, Amer, Verma, Sunil

“…Patients with HER2-positive early breast cancer (EBC) preferred subcutaneous (s.c.) trastuzumab, delivered via single-use injection device (SID), over the…”
Get full text